Eunjeong Kim, MD
Cardiac Electrophysiology · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 10
- 5 carriers
- Offices
- 8
Offices
8 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: El Camino Health · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
10 plans · 5 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Kim’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
10 of 10 plans
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A161592 · Current
Licensed to practise in California · since 2019 · expires 2027-03-31 · Boston University School of Medicine.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$90,073
Medicare paid this office $90,073 for 337 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 94 | $21,090 | $171 |
| Return visit (30+ min) | 54 | $7,394 | $121 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 158 | $5,424 | $26 |
| New patient visit (60+ min) | 24 | $4,991 | $208 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 12 | $4,627 | $386 |
See all 13 services
| Long return visit (40+ min) | 94 | $21,090 | $171 |
| Return visit (30+ min) | 54 | $7,394 | $121 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 158 | $5,424 | $26 |
| New patient visit (60+ min) | 24 | $4,991 | $208 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 12 | $4,627 | $386 |
| Programming of dual lead pacemaker system | 52 | $4,590 | $71 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,342 | $156 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 54 | $2,169 | $33 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $2,135 | $107 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 119 | $2,025 | $14 |
| New patient visit (45+ min) | 12 | $1,879 | $157 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 12 | $1,210 | $22 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 15 | $929 | $62 |
Procedures Medicare counted
| Pacemaker insertion or repair | 31 | More than 79% of doctors who do this |
Who their Medicare patients are
337 Original Medicare patients in 2024. Average age 82 · 85 and older 42% · Women 41% · Also on Medicaid 13% · Health risk score 1.66. At or below the middle of the specialty; the typical clinical cardiac electrophysiology clinician is at 1.8.
Conditions among them: High blood pressure 75% · Atrial fibrillation 71% · Coronary heart disease 48% · Heart failure 46% · Diabetes 32% · Chronic kidney disease 31% · Cancer 20% · COPD 15% · Dementia 14% · Stroke 13% · Depression 12%.
The office billed $381,933, Medicare allowed $113,267 and paid $90,073; for 963 services of 50 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 337 | 963 | 82 | 1.66 | $381,933 | $90,073 |
| 2023 | 502 | 2,495 | 81 | 1.55 | $929,465 | $218,148 |
| 2022 | 516 | 3,259 | 80 | 1.56 | $1,122,652 | $279,633 |
| 2021 | 412 | 1,547 | 80 | 1.49 | $536,856 | $150,738 |
| 2018 | 13 | 13 | 78 | 1.95 | $10,856 | $1,653 |
| 2017 | 16 | 16 | 65 | 1.77 | $12,704 | $2,147 |
| 2016 | 110 | 281 | 74 | 3.84 | $113,587 | $24,817 |
| 2015 | 295 | 752 | 75 | 3.03 | $297,885 | $68,122 |
| 2014 | 238 | 624 | 73 | 2.66 | $228,692 | $52,790 |
| 2013 | 96 | 256 | 71 | 3.09 | $83,096 | $19,094 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 28 services
| Long return visit (40+ min) | 169 | $43,263 | $149 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 30 | $24,418 | $788 |
| Return visit (30+ min) | 122 | $18,441 | $112 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 208 | $13,917 | $26 |
| New patient visit (60+ min) | 70 | $13,754 | $196 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 24 | $8,902 | $262 |
| Programming of dual lead pacemaker system | 87 | $5,948 | $48 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 13 | $5,868 | $451 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 71 | $5,565 | $32 |
| Heart rhythm recording, analysis, interpretation and report of continous external ekg over more than 1 week up to 1 weeks | 15 | $4,851 | $303 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 213 | $4,328 | $12 |
| Insertion of catheters for recording and pacing of left lower heart chamber rhythm and induction of abnormal rhythm | 27 | $3,929 | $146 |
| Removal and replacement of dual lead permanent pacemaker | 11 | $3,286 | $299 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $3,114 | $142 |
| Programming of heart rhythm stimulation after drug infusion | 32 | $2,527 | $77 |
| Telephone medical discussion with physician, 21-30 minutes | 26 | $2,472 | $80 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 14 | $2,302 | $96 |
| Programming of dual lead implantable defibrillator system | 25 | $2,253 | $56 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 41 | $1,975 | $24 |
| Programming of multiple lead implantable defibrillator system | 19 | $1,970 | $70 |
| External shock to heart to regulate heart beat | 17 | $1,968 | $98 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 14 | $1,808 | $23 |
| New patient visit (45+ min) | 13 | $1,678 | $129 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 12 | $815 | $68 |
| Programming of multiple lead pacemaker system | 11 | $687 | $53 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 25 | $651 | $24 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 20 | $470 | $24 |
| Heart rhythm recording of continous external ekg over 8-15 days | 20 | $266 | $13 |
2022: 28 services
| Long return visit (40+ min) | 181 | $58,427 | $157 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 28 | $28,877 | $963 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 237 | $19,198 | $27 |
| New patient visit (60+ min) | 80 | $16,444 | $206 |
| Return visit (30+ min) | 98 | $14,573 | $108 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 26 | $11,260 | $268 |
| Insertion of implantable defibrillator system | 13 | $10,620 | $817 |
| Programming of dual lead pacemaker system | 101 | $8,630 | $52 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 80 | $7,929 | $33 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 51 | $5,846 | $24 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 225 | $5,694 | $13 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 12 | $4,876 | $406 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $4,008 | $167 |
| Removal and replacement of dual lead permanent pacemaker | 12 | $3,846 | $320 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 22 | $3,401 | $92 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 11 | $3,225 | $269 |
| Telephone medical discussion with physician, 21-30 minutes | 27 | $3,098 | $97 |
| Programming of multiple lead implantable defibrillator system | 23 | $2,695 | $69 |
| Programming of dual lead implantable defibrillator system | 28 | $2,531 | $56 |
| Insertion of catheters for recording and pacing of left lower heart chamber rhythm and induction of abnormal rhythm | 16 | $2,525 | $149 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 40 | $2,180 | $24 |
| Programming of heart rhythm stimulation after drug infusion | 20 | $2,005 | $100 |
| Programming of multiple lead pacemaker system | 16 | $1,667 | $41 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 37 | $984 | $25 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 13 | $765 | $59 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 20 | $649 | $22 |
| Heart rhythm recording of continous external ekg over 8-15 days | 38 | $621 | $15 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 20 | $453 | $16 |
2021: 18 services
| Long return visit (40+ min) | 154 | $43,232 | $174 |
| Return visit (30+ min) | 67 | $10,570 | $126 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 193 | $8,727 | $28 |
| Programming of dual lead pacemaker system | 65 | $4,533 | $52 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 64 | $3,452 | $35 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 13 | $3,402 | $262 |
| New patient visit (60+ min) | 16 | $3,396 | $212 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 40 | $3,385 | $25 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $3,119 | $183 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 153 | $2,887 | $15 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $2,082 | $95 |
| Programming of dual lead implantable defibrillator system | 16 | $1,398 | $67 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 21 | $1,355 | $65 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 16 | $429 | $25 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 13 | $369 | $28 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 11 | $298 | $23 |
| Heart rhythm recording of continous external ekg over 8-15 days | 16 | $285 | $17 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 11 | $218 | $17 |
2016: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 68 | $13,653 | $84 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 25 | $3,907 | $156 |
| Hospital discharge day management, more than 30 minutes | 39 | $3,380 | $87 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 28 | $2,150 | $58 |
2015: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 177 | $33,122 | $85 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 59 | $9,992 | $167 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 95 | $8,365 | $59 |
| Hospital discharge day management, more than 30 minutes | 85 | $7,686 | $89 |
| Critical care, first 30-74 minutes | 16 | $3,100 | $182 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 27 | $3,088 | $110 |
2014: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 109 | $18,457 | $85 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 102 | $11,587 | $58 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 50 | $8,225 | $158 |
| Hospital discharge day management, more than 30 minutes | 84 | $7,437 | $86 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $1,804 | $113 |
2013: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 57 | $8,153 | $57 |
| Hospital discharge day management, more than 30 minutes | 36 | $3,114 | $86 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $3,072 | $162 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,157 | $83 |
Medicaid work
$714 in 2024
Medicaid paid $714 for 111 billed services this clinician did in 2024, up to 79 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 111 | $714 |
| 2024 | 111 | 1 | 79 | $714 |
| 2023 | 154 | 1 | 73 | $784 |
| 2022 | 53 | 1 | 50 | $287 |
See the largest Medicaid services in earlier years
2023
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 154 | $784 |
2022
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 53 | $287 |
Drugs they prescribed that Part D paid
$246,747
Pharmacies billed $246,747 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 579) in 2024. At or below the middle of the specialty; the typical clinical cardiac electrophysiology clinician is at 0%.
414 generic and 165 brand-name prescriptions · $246,747 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 99 | $149,104 | $1,506 |
| Xarelto | 36 | $57,293 | $1,591 |
| Flecainide Acetate | 60 | $2,466 | $41 |
| Metoprolol | 98 | $2,072 | $21 |
| Diltiazem 24hr Er (Cd) | 18 | $468 | $26 |
See all 13 drugs
| Eliquis | 99 | $149,104 | $1,506 |
| Xarelto | 36 | $57,293 | $1,591 |
| Flecainide Acetate | 60 | $2,466 | $41 |
| Metoprolol | 98 | $2,072 | $21 |
| Diltiazem 24hr Er (Cd) | 18 | $468 | $26 |
| Diltiazem 24hr Er | 11 | $368 | $33 |
| Atorvastatin | 15 | $328 | $22 |
| Amiodarone | 21 | $297 | $14 |
| Lisinopril | 29 | $247 | $9 |
| Carvedilol | 12 | $240 | $20 |
| Amlodipine Besylate | 11 | $167 | $15 |
| Furosemide | 19 | $134 | $7 |
| Losartan | 19 | $97 | $5 |
Year by year
| 2024 | 579 | 137 | 0% (0) | 28% | $246,747 |
| 2023 | 1,033 | 185 | None | None | $409,912 |
| 2022 | 932 | 196 | None | None | $297,752 |
| 2021 | 201 | 78 | 0% (0) | 30% | $57,747 |
| 2016 | 64 | 22 | None | 31% | $9,518 |
| 2015 | 99 | 45 | 12% (12) | None | $4,983 |
| 2014 | 122 | 41 | None | None | $7,051 |
| 2013 | 375 | 46 | 7% (27) | 20% | $23,531 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 20 drugs
| Eliquis | 138 | $212,882 | $1,543 |
| Xarelto | 66 | $99,859 | $1,513 |
| Entresto | 28 | $41,833 | $1,494 |
| Jardiance | 16 | $17,452 | $1,091 |
| Flecainide Acetate | 105 | $6,585 | $63 |
| Metoprolol | 187 | $4,672 | $25 |
| Amiodarone | 56 | $1,534 | $27 |
| Diltiazem 24hr Er (Cd) | 39 | $1,238 | $32 |
| Losartan | 33 | $556 | $17 |
| Sotalol | 27 | $542 | $20 |
| Torsemide | 11 | $489 | $44 |
| Amlodipine Besylate | 31 | $476 | $15 |
| Potassium Chloride | 16 | $447 | $28 |
| Carvedilol | 19 | $306 | $16 |
| Lisinopril | 31 | $205 | $7 |
| Furosemide | 26 | $186 | $7 |
| Spironolactone | 19 | $174 | $9 |
| Cephalexin | 22 | $172 | $8 |
| Atenolol | 18 | $160 | $9 |
| Omeprazole | 11 | $39 | $4 |
2022: 17 drugs
| Eliquis | 137 | $184,936 | $1,350 |
| Xarelto | 47 | $61,499 | $1,308 |
| Flecainide Acetate | 73 | $4,420 | $61 |
| Metoprolol | 150 | $3,857 | $26 |
| Amiodarone | 87 | $2,418 | $28 |
| Diltiazem 24hr Er (Cd) | 27 | $652 | $24 |
| Sotalol | 32 | $462 | $14 |
| Amlodipine Besylate | 27 | $280 | $10 |
| Potassium Chloride | 16 | $220 | $14 |
| Cephalexin | 33 | $174 | $5 |
| Losartan | 20 | $158 | $8 |
| Carvedilol | 14 | $140 | $10 |
| Furosemide | 27 | $131 | $5 |
| Lisinopril | 38 | $128 | $3 |
| Simvastatin | 14 | $126 | $9 |
| Omeprazole | 15 | $81 | $5 |
| Atorvastatin | 13 | $71 | $5 |
2021: 6 drugs
| Eliquis | 31 | $32,879 | $1,061 |
| Xarelto | 17 | $16,911 | $995 |
| Flecainide Acetate | 14 | $673 | $48 |
| Amiodarone | 17 | $601 | $35 |
| Metoprolol | 23 | $327 | $14 |
| Furosemide | 11 | $29 | $3 |
2013: 12 drugs
| Colcrys | 20 | $5,164 | $258 |
| Fentanyl | 12 | $2,928 | $244 |
| Metoprolol | 17 | $468 | $28 |
| Atorvastatin | 28 | $442 | $16 |
| Omeprazole | 17 | $204 | $12 |
| Metformin | 25 | $193 | $8 |
| Lisinopril | 23 | $118 | $5 |
| Finasteride | 12 | $106 | $9 |
| Glipizide | 17 | $103 | $6 |
| Amlodipine Besylate | 11 | $72 | $7 |
| Metoprolol | 11 | $55 | $5 |
| Furosemide | 11 | $39 | $4 |
Money from drug and device companies
$264 in 2025
| 2025 | 3 | 6 | None | $264 |
| 2024 | 7 | 13 | None | $277 |
| 2023 | 11 | 42 | $3,600 | $5,015 |
| 2022 | 13 | 68 | $1,500 | $7,329 |
| 2021 | 8 | 20 | None | $1,059 |
| 2020 | 3 | 20 | None | $26,970 |
| 2019 | 4 | 61 | None | $9,438 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AtriCure | Epi-Sense Guided Coagulation System With Visitrax | $136 | 1 payment
|
| Biosense Webster | Carto 3 | $104 | 4 payments
|
| Baxter Healthcare | Hillrom - Carnation Ambulatory Monitor | $24 | 1 payment
|
See all 6 published payments
| Biosense Webster | Meals · 2025-10-23 | Carto 3 | $30 |
| Baxter Healthcare | Meals · 2025-06-06 | Hillrom - Carnation Ambulatory Monitor | $24 |
| Biosense Webster | Meals · 2025-05-19 | Carto 3 | $22 |
| Biosense Webster | Meals · 2025-05-16 | Carto 3 | $30 |
| Biosense Webster | Meals · 2025-05-01 | Carto 3 | $22 |
| AtriCure | Meals · 2025-03-20 | Epi-Sense Guided Coagulation System With Visitrax | $136 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $277
| Biosense Webster | Qdot Micro Catheter | $71 | 2 payments
|
| Janssen Pharmaceuticals | Xarelto | $45 | 2 payments
|
| Edwards Lifesciences | Edwards Sapien 3 Ultra Transcatheter Heart Valve | $39 | 2 payments
|
| Boston Scientific | Watchman Flx | $36 | 2 payments
|
| Amgen | Repatha | $35 | 2 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $27 | 2 payments
|
| Novartis Pharmaceuticals | Leqvio | $25 | 1 payment
|
2023: $5,015
| Medical Device Business Services | Carto 3 | $3,600 | 1 payment
|
| Abbott Laboratories | Ensite Precision | $618 | 12 payments
|
| Biosense Webster | Carto 3 | $453 | 13 payments
|
| Pfizer | Eliquis | $98 | 4 payments
|
| Baxter Healthcare | Hillrom - Cardiac Ambulatory Monitor | $57 | 2 payments
|
| Boston Scientific | Lux-Dx Insertable Cardiac Monitor | $48 | 2 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $44 | 3 payments
|
| Novartis Pharmaceuticals | Leqvio | $44 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $19 | 1 payment
|
| Medtronic | Na | $19 | 1 payment
|
| Terumo Medical | Azur Cx Detachable | $15 | 1 payment
|
2022: $7,329
| Abbott Laboratories | Ensite Precision | $3,212 | 32 payments
|
| Boston Scientific | General - Therapies | $1,500 | 1 payment
|
| Medical Device Business Services | Carto 3 | $1,467 | 5 payments
|
| Biosense Webster | Carto 3 | $609 | 11 payments
|
| Medtronic | Micra | $177 | 2 payments
|
| Alnylam Pharmaceuticals | Onpattro | $99 | 4 payments
|
| Bardy Diagnostics | Carnation Ambulatory Monitor | $81 | 2 payments
|
| Pfizer | Eliquis | $66 | 3 payments
|
| Novartis Pharmaceuticals | Entresto | $37 | 2 payments
|
| Janssen Pharmaceuticals | Xarelto | $22 | 1 payment
|
| Kiniksa Pharmaceuticals | Arcalyst | $20 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $20 | 1 payment
|
| Impulse Dynamics (USA) | Optimizer | $19 | 1 payment
|
2021: $1,059
| Abbott Laboratories | Ensite Precision Cardiac Mapping System | $343 | 3 payments
|
| Medtronic | Micra | $214 | 2 payments
|
| Biotronik | Acticor | $160 | 2 payments
|
| Esperion Therapeutics | Nexletol | $95 | 4 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $86 | 2 payments
|
| Janssen Pharmaceuticals | Xarelto | $81 | 4 payments
|
| Novartis Pharmaceuticals | Entresto | $41 | 2 payments
|
| Biosense Webster | Carto 3 | $40 | 1 payment
|
2020: $26,970
| Medtronic Vascular | Micra | $26,698 | 15 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $160 | 2 payments
|
| Abbott Laboratories | Agilis Nxt Ep Introducer | $113 | 3 payments
|
2019: $9,438
| Medtronic Vascular | Azure | $3,750 | 31 payments
|
| Medical Device Business Services | Carto 3 System | $2,195 | 13 payments
|
| Abbott Laboratories | Ensite Cardiac Mapping System | $1,847 | 16 payments
|
| Boston Scientific | General Brady | $1,646 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 83.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1104147834
- Licence
- CA 161592, MA 244824California A161592: Current · expires 2027-03-31
- Trained
- Boston University School of Medicine, 2010
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Cardiology (207RC0000X)
- Mailing address
- Po Box 276950, Sacramento, CA, 95827
- NPI first listed
- 2010-06-16
- NPI last updated
- 2025-01-22
- NPI record certified
- 2025-01-22
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 400 Parnassus Ave Fl 5, San Francisco, CA, 94143